Glycolysis‐derived L‐serine in hippocampal astrocytes rescues synaptic plasticity and memory loss in a mouse model of Alzheimer’s disease

Gilles Bonvento

DOI: https://doi.org/10.1002/alz.060044

2022-12-01

Abstract:Impairment of glycolysis has often been observed early in the course of Alzheimer’s disease, although it is not known whether this deregulation contributes to the cognitive deficits observed in the disease. Aside from ATP production, a major function of glycolysis is to provide precursors, such as L‐serine, to support macromolecular synthesis. L‐serine is a metabolic hub and plays pivotal role in the brain. It is the precursor of D‐serine, the principal co‐agonist of synaptic N‐methyl D‐aspartate receptors (NMDARs) required for the induction of long‐term synaptic plasticity in the hippocampus. It also contributes to the homeostasis of synapses and of mitochondrial function by providing lipids. We used young female 3xTG‐AD mice to determine whether a shortage in the synthesis of L‐serine produced by hippocampal astrocytes from a glycolytic intermediate is responsible for the impairment of synaptic plasticity and spatial memory. We found that 3xTG‐AD mice in the early stage of the disease have reduced extracellular L‐serine levels in the hippocampus where in vivo glucose metabolism is reduced, but not in the frontal cortex that does not present metabolic alterations. Acute application of D‐serine or L‐serine rescues long‐term synaptic plasticity and chronic oral L‐serine supplementation restores memory deficits in AD mice. Such chronic treatment also restores the atrophy of hippocampal astrocytes in these AD‐mice. These results indicate that a metabolic deficit of L‐serine synthesis by astrocytes contributes to cognitive deficits in AD.

clinical neurology